Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Tumor|Breast Cancer
Interventions: DRUG: NKTR-102|DRUG: NKTR-102
Sponsor: Nektar Therapeutics